Skip to search boxSkip to navigationSkip to main content

Detection of rare β-lactamase blaSCO-1 from a Klebsiella pneumoniae high-risk clone in Peru

  • Luciano A. Palomino-Kobayashif(Author)
    ,
  • Rocío Egoávil-Espejoe(Author)
    ,
  • Gina Salvador-Lujánb, g(Author)
    ,
  • Pamela Yáñezd(Author)
    ,
  • Ronnie G. Gavilánc, d(Author)
    ,
  • Maria J. Ponsa(Author)
  • ,
  • bHospital Militar Central
    ,
  • cUniversidad Privada San Juan Bautista
    ,
  • dInstituto Nacional de Salud, Lima
    ,
  • eUniversidad Científica del Sur
    ,
  • fUniversidad Nacional Mayor de San Marcos
Research Output: Contribution to journal Article Peer-review

Open access

Publication Information

Output type

Research Output: Contribution to journal Article Peer-review

Original language

English

Article number

dlaf089

Journal (Volume, Issue Number)

JAC-Antimicrobial Resistance (Volume 7, Issue 3)

Publication milestones

    Published
    - 01/06/2025

Publication status

Published
- 01/06/2025

External Publication IDs

  • Scopus: 105006732124

Abstract

Background: The blaSCO-1 gene, which codes for a carbenicillinase, is an uncommon β-lactamase. To the best of our knowledge, we report the first instance of a Klebsiella pneumoniae clinical high-risk isolate carrying blaSCO-1 in Peru. Objectives: To characterize a K. pneumoniae clinical isolate carrying blaSCO-1 in Peru, isolated from a tertiary care hospital in Lima, Peru. Methods: Susceptibility to amoxicillin/clavulanic acid, amoxicillin/sulbactam, piperacillin/tazobactam, aztreonam, ceftriaxone, cefotaxime, ceftazidime, ceftazidime/avibactam, cefepime, imipenem, meropenem, ciprofloxacin, trimethoprim/sulfamethoxazole, gentamicin, amikacin and tigecycline was determined using the Kirby–Bauer disc diffusion method. Detection of blaSCO-1 was established by Illumina WGS and bioinformatic analyses. All the publicly available genomes from K. pneumoniae carrying blaSCO-1 from the American continent were downloaded from the NCBI Isolates browser for assessment of phylogenetic comparisons. Results: The isolate showed resistance to all the tested antibiotics except for ceftazidime/avibactam, carbapenems and tigecycline. Illumina WGS showed the presence of blaSCO-1 and blaOXA-1, blaSHV-28, blaTEM-1, blaCTX-M-15, as well as genes associated with resistance to quinolones, fosfomycin, aminoglycosides, sulphonamides, trimethoprim and phenicols. Moreover, the isolate was ST307, a high-risk clone of K. pneumoniae usually associated with blaCTX-M-15 and/or carbapenemases. Notwithstanding, the latter were not found on this isolate. Phylogenetic relationships were established by comparisons with 19 K. pneumoniae genomes carrying blaSCO-1 from other countries in the Americas, revealing at least three different clades. Conclusions: This study highlights the importance of genomic surveillance of uncommon antimicrobial resistance genes such as blaSCO-1, which might contribute to further antimicrobial resistance levels in this country.

Access to documents

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well